Skip to main content

Leveraging multimodal data fusion for target discovery.

20 Jun 2024
Salon B
Target Identification
  • If you had unlimited budget, would you rather collect datasets that are broad (2000-patient cohort with 5+ modalities) or deep (10,000 patients with 2 modalities)?
  • What are valuable insights that have emerged from third-party vendors of bundled clinical and multi-omics data?
  • What benchmarks will we need to see from Foundation Models before they are ready for prime time?
Industry Expert
Derek Chiang, Vice President and Head, Computational Biology - Bayer Pharmaceuticals